Maze Therapeutics Inc.
MAZE | NASDAQ
$27.35
+$4.96 (+22.15%)
Sep 22, 2026, 11:19 AM ET · Market open
Institutional Ownership
Net InflowTotal Institutions
176
Total Ownership
95.88%
Capital Flow
+$460.5M
Shares Change
+3.31M
Ownership Distribution
Institutions (95.88%)
Others (4.12%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
50
Increased Positions
109
Reduced Positions
36
Closed Positions
27
New (50)
Increased (109)
Reduced (36)
Closed (27)
Options Sentiment & Activity
bullishPut/Call Ratio
0.385
Call Flow
324,500
Put Flow
125,000
Calls (72%)
Puts (28%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0.03% -41.70% | < 0.01% | 15.8K | 434.97K |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.p. | 8.47% -20.26% | 3.51% -30.98% | 4.57M 0.00% | 136.33M -27.95% | |
| Trv Gp Iv, LLC | 8.30% -20.26% | 50.04% -31.13% | 4.47M 0.00% | 133.55M -27.95% | |
| Arch Venture Management, LLC | 7.64% -20.26% | 18.16% -30.65% | 4.12M 0.00% | 122.98M -27.95% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove MAZE